GM Advisory Group LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,240 shares of the medical equipment provider’s stock after selling 31 shares during the period. GM Advisory Group LLC’s holdings in Intuitive Surgical were worth $2,213,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of ISRG. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $31,000. Finally, MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on ISRG. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Barclays raised their price objective on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Citigroup raised their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Robert W. Baird decreased their price objective on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday. Finally, Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $611.86.
Insider Activity at Intuitive Surgical
In related news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last ninety days. 0.90% of the stock is owned by corporate insiders.
Intuitive Surgical Stock Performance
Shares of ISRG stock opened at $483.95 on Wednesday. The firm has a market cap of $172.37 billion, a P/E ratio of 75.50, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The business’s 50 day moving average price is $565.43 and its 200-day moving average price is $531.90.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- What is a Stock Market Index and How Do You Use Them?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Must-Own Stocks to Build Wealth This Decade
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.